Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004875 · ClinicalTrials.gov registry record
Heparin or Enoxaparin in Patients With Cancer
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 6
- Enrollment target
NCT00004875: Completed study, sponsored by Northwestern University.
NCT00004875 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004875 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
RATIONALE: Heparin or enoxaparin may be effective in preventing the formation of blood clots in patients with cancer who are undergoing surgery to remove the tumor. PURPOSE: Randomized clinical trial to compare the effectiveness of heparin with that of enoxaparin in patients who have cancer.
Interventions
- DRUG enoxaparin
- DRUG heparin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 1996-07 |
| Est. Completion | 1999-03 |
What the finished NCT00004875 record still lists
NCT00004875 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which enoxaparin is the first listed.
NCT00004875 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004875 about?
NCT00004875 is a clinical study titled "Heparin or Enoxaparin in Patients With Cancer". RATIONALE: Heparin or enoxaparin may be effective in preventing the formation of blood clots in patients with cancer who are undergoing surgery to remove the tumor. PURPOSE: Randomized clinical trial to compare the effectiveness of heparin with that of enoxaparin in patients who have cancer.
What is the current status of trial NCT00004875?
This trial is currently completed. The enrollment target is 6 participants. The study started on 1996-07. Estimated completion is 1999-03.
What interventions are being tested in trial NCT00004875?
The interventions under investigation include: enoxaparin (DRUG), heparin (DRUG).
Who is sponsoring clinical trial NCT00004875?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia